Crossmark

An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient

Crossref DOI link: https://doi.org/10.1038/s41589-018-0222-1

Published Online: 2019-01-28

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Quancard, Jean https://orcid.org/0000-0001-6324-8490
Klein, Theo https://orcid.org/0000-0001-8061-9353
Fung, Shan-Yu

Renatus, Martin https://orcid.org/0000-0002-7348-2915
Hughes, Nicola https://orcid.org/0000-0002-9528-8558
Israël, Laura https://orcid.org/0000-0002-4385-6517
Priatel, John J. https://orcid.org/0000-0001-8794-6306
Kang, Sohyeong

Blank, Michael A.

Viner, Rosa I. https://orcid.org/0000-0003-0550-5545
Blank, Jutta https://orcid.org/0000-0002-4768-1371
Schlapbach, Achim https://orcid.org/0000-0001-8137-8889
Erbel, Paul https://orcid.org/0000-0002-6336-3445
Kizhakkedathu, Jayachandran https://orcid.org/0000-0001-7688-7574
Villard, Frédéric

Hersperger, René

Turvey, Stuart E. https://orcid.org/0000-0003-1599-1065
Eder, Joerg https://orcid.org/0000-0001-7152-8417
Bornancin, Frédéric https://orcid.org/0000-0002-0152-6720
Overall, Christopher M. https://orcid.org/0000-0001-5844-2731
License Information

Text and Data Mining valid from 2019-01-28
More Information

Article History

Received: 12 December 2017

Accepted: 6 December 2018

First Online: 28 January 2019

Competing interests

: J.Q., M.R., N.H., L.I., J.B., A.S., P.E., F.V., R.H., J.E., and F.B. are employees of the Novartis Institute of Biomedical Research. R.I.V. is and M.B. was an employee of Thermo Fisher Scientific, developer and distributor of the Orbitrap Fusion Lumos mass spectrometer.